Literature DB >> 22977500

Quality of life of lung cancer patients receiving outpatient chemotherapy.

Ayako Matsuda1, Mika Kobayashi, Yumi Sakakibara, Meiyo Tamaoka, Masashi Furuiye, Naohiko Inase, Eisuke Matsushima.   

Abstract

An increasing number of cancer patients receive outpatient chemotherapy as an alternative to inpatient chemotherapy. The aim of this study was to investigate whether quality of life (QOL) during outpatient chemotherapy was better than QOL prior to hospital discharge, and to explore possible related factors prior to hospital discharge that affected the QOL of lung cancer patients who received outpatient chemotherapy. Lung cancer inpatients who were scheduled for outpatient chemotherapy were assessed two times (prior to hospital discharge and during outpatient chemotherapy) using the Functional Assessment of Cancer Therapy-Lung and Hospital Anxiety and Depression Scale. A total of 40 patients completed all assessments, both prior to hospital discharge and during outpatient chemotherapy. In the present study, QOL during outpatient chemotherapy was not significantly different when compared with the QOL prior to hospital discharge, and predictors prior to hospital discharge for a better QOL of patients during outpatient chemotherapy included better social, emotional and physical well-being. These results suggest that medical staff, in particular those involved in outpatient chemotherapy, need to recognize social and emotional as well as physical well-being prior to hospital discharge, regardless of cancer-related factors and the personal characteristics of the patients.

Entities:  

Year:  2011        PMID: 22977500      PMCID: PMC3440648          DOI: 10.3892/etm.2011.185

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Assessment of anxiety and depression in advanced cancer patients and their relationship with quality of life.

Authors:  K Mystakidou; E Tsilika; E Parpa; E Katsouda; A Galanos; L Vlahos
Journal:  Qual Life Res       Date:  2005-10       Impact factor: 4.147

2.  Non-small cell lung cancer.

Authors:  David S Ettinger; Wallace Akerley; Gerold Bepler; Andrew Chang; Richard T Cheney; Lucian R Chirieac; Thomas A D'Amico; Todd L Demmy; Steven J Feigenberg; Robert A Figlin; Ramaswamy Govindan; Frederic W Grannis; Thierry Jahan; Mohammad Jahanzeb; Anne Kessinger; Ritsuko Komaki; Mark G Kris; Corey J Langer; Quynh-Thu Le; Renato Martins; Gregory A Otterson; Jyoti D Patel; Francisco Robert; David J Sugarbaker; Douglas E Wood
Journal:  J Natl Compr Canc Netw       Date:  2008-03       Impact factor: 11.908

Review 3.  Small-cell lung cancer: treatment progress and prospects.

Authors:  R Clark; D C Ihde
Journal:  Oncology (Williston Park)       Date:  1998-05       Impact factor: 2.990

4.  Quality of life in patients with lung cancer: a review of literature from 1970 to 1995.

Authors:  A Montazeri; C R Gillis; J McEwen
Journal:  Chest       Date:  1998-02       Impact factor: 9.410

5.  [Outpatient chemotherapy for lung cancer].

Authors:  Shuichi Yoneda
Journal:  Gan To Kagaku Ryoho       Date:  2007-04

Review 6.  Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease.

Authors:  Silvia Novello; Thierry Le Chevalier
Journal:  Oncology (Williston Park)       Date:  2003-03       Impact factor: 2.990

7.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale.

Authors:  P J Hollen; R J Gralla; M G Kris; C Cox; C P Belani; S M Grunberg; J Crawford; J A Neidhart
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

9.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

Authors:  D F Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

10.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

View more
  1 in total

1.  Demand for weekend outpatient chemotherapy among patients with cancer in Japan.

Authors:  Hideki Katayama; Masahiro Tabata; Toshio Kubo; Katsuyuki Kiura; Junji Matsuoka; Yoshinobu Maeda
Journal:  Support Care Cancer       Date:  2020-07-04       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.